Brain metastases
AS Achrol, RC Rennert, C Anders, R Soffietti… - Nature Reviews …, 2019 - nature.com
An estimated 20% of all patients with cancer will develop brain metastases, with the majority
of brain metastases occurring in those with lung, breast and colorectal cancers, melanoma …
of brain metastases occurring in those with lung, breast and colorectal cancers, melanoma …
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …
NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
Emerging treatment strategies for glioblastoma multiforme
SK Carlsson, SP Brothers… - EMBO molecular medicine, 2014 - embopress.org
Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5‐
year mortality. GBM has a paltry median survival of 12.6 months attributed to the unique …
year mortality. GBM has a paltry median survival of 12.6 months attributed to the unique …
PET imaging in neuro-oncology: An update and overview of a rapidly growing area
Simple Summary Positron emission tomography (PET) is a functional imaging technique
which plays an increasingly important role in the management of brain tumors. Owing …
which plays an increasingly important role in the management of brain tumors. Owing …
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy–detecting illusive disease, defining response
Glioblastoma, the most common malignant primary brain tumor in adults is a devastating
diagnosis with an average survival of 14–16 months using the current standard of care …
diagnosis with an average survival of 14–16 months using the current standard of care …
Primary CNS lymphomas: challenges in diagnosis and monitoring
C Chiavazza, A Pellerino, F Ferrio… - BioMed research …, 2018 - Wiley Online Library
Primary Central Nervous System Lymphoma (PCNSL) is a rare neoplasm that can involve
brain, eye, leptomeninges, and rarely spinal cord. PCNSL lesions most typically enhance …
brain, eye, leptomeninges, and rarely spinal cord. PCNSL lesions most typically enhance …
Advanced imaging techniques for newly diagnosed and recurrent gliomas
LR Carrete, JS Young, S Cha - Frontiers in Neuroscience, 2022 - frontiersin.org
Management of gliomas following initial diagnosis requires thoughtful presurgical planning
followed by regular imaging to monitor treatment response and survey for new tumor growth …
followed by regular imaging to monitor treatment response and survey for new tumor growth …
Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant …
JA Boockvar, AJ Tsiouris, CP Hofstetter… - Journal of …, 2011 - thejns.org
Object The authors assessed the safety and maximum tolerated dose of superselective
intraarterial cerebral infusion (SIACI) of bevacizumab after osmotic disruption of the blood …
intraarterial cerebral infusion (SIACI) of bevacizumab after osmotic disruption of the blood …
Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and 18F …
K Yamashita, T Yoshiura, A Hiwatashi, O Togao… - Neuroradiology, 2013 - Springer
Introduction Our purpose was to evaluate the diagnostic performance of arterial spin
labeling (ASL) perfusion imaging, diffusion-weighted imaging (DWI), and 18 F …
labeling (ASL) perfusion imaging, diffusion-weighted imaging (DWI), and 18 F …